ACC 2019: Corevalve low-risk TAVR trial - Prof Michael J Reardon & Dr Nicolas van Mieghem

ACC 2019: Corevalve low-risk TAVR trial - Prof Michael J Reardon & Dr Nicolas van MieghemПодробнее

ACC 2019: Corevalve low-risk TAVR trial - Prof Michael J Reardon & Dr Nicolas van Mieghem

Evolut Low Risk | ACC.19Подробнее

Evolut Low Risk | ACC.19

Low Risk TAVR: What the Data Tells Us (Michael J. Reardon, MD) March 26, 2020Подробнее

Low Risk TAVR: What the Data Tells Us (Michael J. Reardon, MD) March 26, 2020

TAVR: Optimizing the Choice of Prosthesis and Patient (MICHAEL J. REARDON, MD)Подробнее

TAVR: Optimizing the Choice of Prosthesis and Patient (MICHAEL J. REARDON, MD)

Live from ACC: Results of the Evolut Low Risk TrialПодробнее

Live from ACC: Results of the Evolut Low Risk Trial

ESC 2019: Wrap-Up - Part 1 - Dr Nicolas Van MieghemПодробнее

ESC 2019: Wrap-Up - Part 1 - Dr Nicolas Van Mieghem

TAVR: The Next 3 YearsПодробнее

TAVR: The Next 3 Years

TAVR and Valve-in-Valve (Michael Reardon, MD)Подробнее

TAVR and Valve-in-Valve (Michael Reardon, MD)

Wrap Up Of ACC 2019: An Analysis Of The Late-Breaking Trials - Dr Nicolas Van MieghemПодробнее

Wrap Up Of ACC 2019: An Analysis Of The Late-Breaking Trials - Dr Nicolas Van Mieghem

Michael J. Reardon, MD: The TAVR Study for Low-Risk MortalityПодробнее

Michael J. Reardon, MD: The TAVR Study for Low-Risk Mortality

The CoreValve™ Evolut™ PRO Transcatheter Aortic Valve (TAVR) SystemПодробнее

The CoreValve™ Evolut™ PRO Transcatheter Aortic Valve (TAVR) System

ACC 22: Findings from the CoreValve US Pivotal & SURTAVI Trials | Dr Michael J ReardonПодробнее

ACC 22: Findings from the CoreValve US Pivotal & SURTAVI Trials | Dr Michael J Reardon

N. Van Mieghem | Mechanisms of coronary obstruction during TAVR.Подробнее

N. Van Mieghem | Mechanisms of coronary obstruction during TAVR.

The Treatment of Aortic Valve Disease in 2020, A Surgeon’s Perspective (Michael J. Reardon, MD)Подробнее

The Treatment of Aortic Valve Disease in 2020, A Surgeon’s Perspective (Michael J. Reardon, MD)

How I Managed a Difficult CoreValve TAVR Case - Jeffrey Popma, MDПодробнее

How I Managed a Difficult CoreValve TAVR Case - Jeffrey Popma, MD

ESC 2019: Wrap-Up - Part 2 - Dr Nicolas Van MieghemПодробнее

ESC 2019: Wrap-Up - Part 2 - Dr Nicolas Van Mieghem

Michael J. Reardon, MD: Long-Term TAVR PlansПодробнее

Michael J. Reardon, MD: Long-Term TAVR Plans

PRECISE-TAVI results Prof. Nicolas Van MieghemПодробнее

PRECISE-TAVI results Prof. Nicolas Van Mieghem

Wrap Up Of EuroPCR 2019 - An Analysis Of The Late-Breaking TrialsПодробнее

Wrap Up Of EuroPCR 2019 - An Analysis Of The Late-Breaking Trials